HEADER TRANSFERASE 10-FEB-09 3G7Q TITLE CRYSTAL STRUCTURE OF VALINE-PYRUVATE AMINOTRANSFERASE AVTA TITLE 2 (NP_462565.1) FROM SALMONELLA TYPHIMURIUM LT2 AT 1.80 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: VALINE-PYRUVATE AMINOTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 EC: 2.6.1.66; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SALMONELLA TYPHIMURIUM; SOURCE 3 ORGANISM_TAXID: 602; SOURCE 4 STRAIN: LT2 / SGSC1412; SOURCE 5 ATCC: 700720; SOURCE 6 GENE: AVTA, NP_462565.1, STM3665; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS NP_462565.1, VALINE-PYRUVATE AMINOTRANSFERASE AVTA, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-2, AMINOTRANSFERASE, PYRUVATE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 5 01-FEB-23 3G7Q 1 REMARK SEQADV REVDAT 4 24-JUL-19 3G7Q 1 REMARK LINK REVDAT 3 25-OCT-17 3G7Q 1 REMARK REVDAT 2 13-JUL-11 3G7Q 1 VERSN REVDAT 1 03-MAR-09 3G7Q 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF VALINE-PYRUVATE AMINOTRANSFERASE AVTA JRNL TITL 2 (NP_462565.1) FROM SALMONELLA TYPHIMURIUM LT2 AT 1.80 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.28 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 53818 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.196 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2733 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3658 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.65 REMARK 3 BIN R VALUE (WORKING SET) : 0.2230 REMARK 3 BIN FREE R VALUE SET COUNT : 220 REMARK 3 BIN FREE R VALUE : 0.2420 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2976 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 15 REMARK 3 SOLVENT ATOMS : 278 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 28.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.10000 REMARK 3 B22 (A**2) : 0.10000 REMARK 3 B33 (A**2) : -0.15000 REMARK 3 B12 (A**2) : 0.05000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.100 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.094 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.062 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.953 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.955 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3304 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2232 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4519 ; 1.589 ; 1.975 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5471 ; 1.018 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 435 ; 3.945 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 140 ;32.893 ;24.286 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 548 ;10.367 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;16.627 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 493 ; 0.076 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3805 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 656 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 722 ; 0.229 ; 0.300 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2340 ; 0.183 ; 0.300 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1672 ; 0.180 ; 0.500 REMARK 3 NON-BONDED TORSION OTHERS (A): 1605 ; 0.085 ; 0.500 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 420 ; 0.190 ; 0.500 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 18 ; 0.224 ; 0.300 REMARK 3 SYMMETRY VDW OTHERS (A): 50 ; 0.202 ; 0.300 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 31 ; 0.176 ; 0.500 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2159 ; 1.806 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 831 ; 0.424 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3383 ; 2.677 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1319 ; 4.478 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1136 ; 6.383 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 14 A 416 REMARK 3 ORIGIN FOR THE GROUP (A): -26.0867 59.9990 14.1651 REMARK 3 T TENSOR REMARK 3 T11: -0.0137 T22: -0.0989 REMARK 3 T33: -0.0439 T12: 0.0104 REMARK 3 T13: 0.0222 T23: -0.0165 REMARK 3 L TENSOR REMARK 3 L11: 0.7464 L22: 0.7419 REMARK 3 L33: 0.8540 L12: -0.2478 REMARK 3 L13: 0.2536 L23: -0.1505 REMARK 3 S TENSOR REMARK 3 S11: -0.0484 S12: -0.0440 S13: -0.1681 REMARK 3 S21: 0.0614 S22: 0.0671 S23: 0.0473 REMARK 3 S31: 0.1156 S32: -0.0610 S33: -0.0186 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1.HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2.ATOM RECORD CONTAINS RESIDUAL B FACTORS REMARK 3 ONLY. 3.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE REMARK 3 ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 TO ACCOUNT FOR THE REMARK 3 REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. REMARK 3 4.CHLORIDE IONS AND ETHYLENE GLYCOL MOLECULE FROM REMARK 3 CRYSTALLIZATION ARE MODELED IN THIS STRUCTURE. REMARK 4 REMARK 4 3G7Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-FEB-09. REMARK 100 THE DEPOSITION ID IS D_1000051528. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-NOV-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.91837, 0.97874, 0.97828 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53916 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 29.285 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 10.20 REMARK 200 R MERGE (I) : 0.06600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.2500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.94300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 40.0% ETHYLENE GLYCOL, 0.1M REMARK 280 ACETATE PH 4.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.77667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 151.55333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 113.66500 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 189.44167 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 37.88833 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 75.77667 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 151.55333 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 189.44167 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 113.66500 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 37.88833 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE RESULTS FROM SIZE EXCLUSION CHROMATOGRAPHY SUPPORT THE REMARK 300 ASSIGNMENT OF A DIMER AS A SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.1 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.500000 0.866025 0.000000 -46.14000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 79.91682 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 37.88833 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 THR A 2 REMARK 465 PHE A 3 REMARK 465 SER A 4 REMARK 465 LEU A 5 REMARK 465 PHE A 6 REMARK 465 GLY A 7 REMARK 465 ASP A 8 REMARK 465 LYS A 9 REMARK 465 PHE A 10 REMARK 465 THR A 11 REMARK 465 ARG A 12 REMARK 465 HIS A 13 REMARK 465 SER A 14 REMARK 465 GLY A 26 REMARK 465 LEU A 27 REMARK 465 ARG A 28 REMARK 465 THR A 29 REMARK 465 PRO A 30 REMARK 465 ARG A 121 REMARK 465 ALA A 122 REMARK 465 ASP A 123 REMARK 465 GLY A 124 REMARK 465 SER A 143 REMARK 465 GLY A 144 REMARK 465 LEU A 145 REMARK 465 GLU A 146 REMARK 465 ASP A 147 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 16 CG1 CG2 CD1 REMARK 470 THR A 17 OG1 CG2 REMARK 470 ARG A 18 CG CD NE CZ NH1 NH2 REMARK 470 MSE A 20 CG SE CE REMARK 470 ASN A 24 CB CG OD1 ND2 REMARK 470 ASP A 25 CB CG OD1 OD2 REMARK 470 TYR A 70 CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 76 CG CD CE NZ REMARK 470 ARG A 120 CG CD NE CZ NH1 NH2 REMARK 470 SER A 125 OG REMARK 470 ASP A 148 CG OD1 OD2 REMARK 470 LEU A 149 CG CD1 CD2 REMARK 470 HIS A 175 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 178 CG CD OE1 OE2 REMARK 470 GLU A 199 CD OE1 OE2 REMARK 470 LYS A 265 CE NZ REMARK 470 ASN A 274 CG OD1 ND2 REMARK 470 ILE A 277 CG1 CG2 CD1 REMARK 470 SER A 278 OG REMARK 470 LEU A 279 CG CD1 CD2 REMARK 470 LYS A 294 CE NZ REMARK 470 ASP A 377 CG OD1 OD2 REMARK 470 LYS A 378 CD CE NZ REMARK 470 LYS A 397 CE NZ REMARK 470 ARG A 411 CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 MSE A 289 SE MSE A 289 CE -0.400 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 206 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 MSE A 387 CG - SE - CE ANGL. DEV. = -13.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 24 -88.57 -97.44 REMARK 500 ARG A 187 105.23 -162.68 REMARK 500 ALA A 233 110.72 -165.77 REMARK 500 LEU A 279 52.21 -117.21 REMARK 500 VAL A 305 -54.53 -121.21 REMARK 500 ALA A 338 -168.78 64.07 REMARK 500 GLU A 415 13.49 -142.42 REMARK 500 GLU A 415 22.70 -148.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 417 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 418 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 419 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 420 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 421 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 422 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 391498 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3G7Q A 1 416 UNP Q8ZL86 Q8ZL86_SALTY 1 416 SEQADV 3G7Q GLY A 0 UNP Q8ZL86 EXPRESSION TAG SEQRES 1 A 417 GLY MSE THR PHE SER LEU PHE GLY ASP LYS PHE THR ARG SEQRES 2 A 417 HIS SER GLY ILE THR ARG LEU MSE GLU ASP LEU ASN ASP SEQRES 3 A 417 GLY LEU ARG THR PRO GLY ALA ILE MSE LEU GLY GLY GLY SEQRES 4 A 417 ASN PRO ALA HIS ILE PRO ALA MSE GLN ASP TYR PHE GLN SEQRES 5 A 417 THR LEU LEU THR ASP MSE VAL GLU SER GLY LYS ALA ALA SEQRES 6 A 417 ASP ALA LEU CYS ASN TYR ASP GLY PRO GLN GLY LYS THR SEQRES 7 A 417 ALA LEU LEU ASN ALA LEU ALA VAL LEU LEU ARG GLU THR SEQRES 8 A 417 LEU GLY TRP ASP ILE GLU PRO GLN ASN ILE ALA LEU THR SEQRES 9 A 417 ASN GLY SER GLN SER ALA PHE PHE TYR LEU PHE ASN LEU SEQRES 10 A 417 PHE ALA GLY ARG ARG ALA ASP GLY SER THR LYS LYS VAL SEQRES 11 A 417 LEU PHE PRO LEU ALA PRO GLU TYR ILE GLY TYR ALA ASP SEQRES 12 A 417 SER GLY LEU GLU ASP ASP LEU PHE VAL SER ALA ARG PRO SEQRES 13 A 417 ASN ILE GLU LEU LEU PRO GLU GLY GLN PHE LYS TYR HIS SEQRES 14 A 417 VAL ASP PHE GLU HIS LEU HIS ILE GLY GLU GLU THR GLY SEQRES 15 A 417 MSE ILE CYS VAL SER ARG PRO THR ASN PRO THR GLY ASN SEQRES 16 A 417 VAL ILE THR ASP GLU GLU LEU MSE LYS LEU ASP ARG LEU SEQRES 17 A 417 ALA ASN GLN HIS ASN ILE PRO LEU VAL ILE ASP ASN ALA SEQRES 18 A 417 TYR GLY VAL PRO PHE PRO GLY ILE ILE PHE SER GLU ALA SEQRES 19 A 417 ARG PRO LEU TRP ASN PRO ASN ILE ILE LEU CYS MSE SER SEQRES 20 A 417 LEU SER LYS LEU GLY LEU PRO GLY SER ARG CYS GLY ILE SEQRES 21 A 417 ILE ILE ALA ASN ASP LYS THR ILE THR ALA ILE ALA ASN SEQRES 22 A 417 MSE ASN GLY ILE ILE SER LEU ALA PRO GLY GLY MSE GLY SEQRES 23 A 417 PRO ALA MSE MSE CYS GLU MSE ILE LYS ARG ASN ASP LEU SEQRES 24 A 417 LEU ARG LEU SER GLU THR VAL ILE LYS PRO PHE TYR TYR SEQRES 25 A 417 GLN ARG VAL GLN GLN THR ILE ALA ILE ILE ARG ARG TYR SEQRES 26 A 417 LEU SER GLU GLU ARG CYS LEU ILE HIS LYS PRO GLU GLY SEQRES 27 A 417 ALA ILE PHE LEU TRP LEU TRP PHE LYS ASP LEU PRO ILE SEQRES 28 A 417 THR THR GLU LEU LEU TYR GLN ARG LEU LYS ALA ARG GLY SEQRES 29 A 417 VAL LEU MSE VAL PRO GLY HIS TYR PHE PHE PRO GLY LEU SEQRES 30 A 417 ASP LYS PRO TRP PRO HIS THR HIS GLN CYS MSE ARG MSE SEQRES 31 A 417 ASN TYR VAL PRO GLU PRO ASP LYS ILE GLU ALA GLY VAL SEQRES 32 A 417 LYS ILE LEU ALA GLU GLU ILE GLU ARG ALA TRP ARG GLU SEQRES 33 A 417 GLY MODRES 3G7Q MSE A 20 MET SELENOMETHIONINE MODRES 3G7Q MSE A 34 MET SELENOMETHIONINE MODRES 3G7Q MSE A 46 MET SELENOMETHIONINE MODRES 3G7Q MSE A 57 MET SELENOMETHIONINE MODRES 3G7Q MSE A 182 MET SELENOMETHIONINE MODRES 3G7Q MSE A 202 MET SELENOMETHIONINE MODRES 3G7Q MSE A 245 MET SELENOMETHIONINE MODRES 3G7Q MSE A 273 MET SELENOMETHIONINE MODRES 3G7Q MSE A 284 MET SELENOMETHIONINE MODRES 3G7Q MSE A 288 MET SELENOMETHIONINE MODRES 3G7Q MSE A 289 MET SELENOMETHIONINE MODRES 3G7Q MSE A 292 MET SELENOMETHIONINE MODRES 3G7Q MSE A 366 MET SELENOMETHIONINE MODRES 3G7Q MSE A 387 MET SELENOMETHIONINE MODRES 3G7Q MSE A 389 MET SELENOMETHIONINE HET MSE A 20 5 HET MSE A 34 16 HET MSE A 46 8 HET MSE A 57 8 HET MSE A 182 8 HET MSE A 202 16 HET MSE A 245 8 HET MSE A 273 8 HET MSE A 284 8 HET MSE A 288 8 HET MSE A 289 16 HET MSE A 292 16 HET MSE A 366 8 HET MSE A 387 8 HET MSE A 389 8 HET CL A 417 1 HET CL A 418 1 HET CL A 419 1 HET EDO A 420 4 HET EDO A 421 4 HET EDO A 422 4 HETNAM MSE SELENOMETHIONINE HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 15(C5 H11 N O2 SE) FORMUL 2 CL 3(CL 1-) FORMUL 5 EDO 3(C2 H6 O2) FORMUL 8 HOH *278(H2 O) HELIX 1 1 GLY A 15 ASP A 25 1 11 HELIX 2 2 ILE A 43 SER A 60 1 18 HELIX 3 3 GLY A 61 ASN A 69 1 9 HELIX 4 4 GLY A 75 GLY A 92 1 18 HELIX 5 5 GLU A 96 GLN A 98 5 3 HELIX 6 6 GLY A 105 ALA A 118 1 14 HELIX 7 7 GLU A 136 ASP A 142 1 7 HELIX 8 8 ASP A 170 LEU A 174 5 5 HELIX 9 9 THR A 197 HIS A 211 1 15 HELIX 10 10 SER A 248 GLY A 251 5 4 HELIX 11 11 ASN A 263 SER A 278 1 16 HELIX 12 12 GLY A 283 ARG A 295 1 13 HELIX 13 13 ASP A 297 VAL A 305 1 9 HELIX 14 14 VAL A 305 LEU A 325 1 21 HELIX 15 15 THR A 351 ARG A 362 1 12 HELIX 16 16 HIS A 370 PHE A 373 5 4 HELIX 17 17 TRP A 380 HIS A 384 5 5 HELIX 18 18 GLU A 394 GLY A 416 1 23 SHEET 1 A 2 ILE A 33 MSE A 34 0 SHEET 2 A 2 VAL A 364 LEU A 365 1 O LEU A 365 N ILE A 33 SHEET 1 B 7 ILE A 100 THR A 103 0 SHEET 2 B 7 GLY A 258 ILE A 261 -1 O ILE A 260 N ALA A 101 SHEET 3 B 7 ILE A 241 SER A 246 -1 N MSE A 245 O ILE A 259 SHEET 4 B 7 LEU A 215 ASP A 218 1 N ILE A 217 O ILE A 242 SHEET 5 B 7 THR A 180 SER A 186 1 N ILE A 183 O VAL A 216 SHEET 6 B 7 LYS A 128 PHE A 131 1 N LYS A 128 O GLY A 181 SHEET 7 B 7 PHE A 150 SER A 152 1 O VAL A 151 N PHE A 131 SHEET 1 C 6 ASN A 156 LEU A 160 0 SHEET 2 C 6 GLN A 164 HIS A 168 -1 O GLN A 164 N LEU A 160 SHEET 3 C 6 LEU A 331 HIS A 333 1 O ILE A 332 N PHE A 165 SHEET 4 C 6 PHE A 340 TRP A 344 -1 O TRP A 344 N LEU A 331 SHEET 5 C 6 CYS A 386 ASN A 390 -1 O MSE A 387 N LEU A 343 SHEET 6 C 6 VAL A 367 PRO A 368 -1 N VAL A 367 O ARG A 388 LINK C LEU A 19 N MSE A 20 1555 1555 1.33 LINK C MSE A 20 N GLU A 21 1555 1555 1.33 LINK C ILE A 33 N AMSE A 34 1555 1555 1.33 LINK C ILE A 33 N BMSE A 34 1555 1555 1.33 LINK C AMSE A 34 N LEU A 35 1555 1555 1.33 LINK C BMSE A 34 N LEU A 35 1555 1555 1.33 LINK C ALA A 45 N MSE A 46 1555 1555 1.33 LINK C MSE A 46 N AGLN A 47 1555 1555 1.32 LINK C MSE A 46 N BGLN A 47 1555 1555 1.33 LINK C ASP A 56 N MSE A 57 1555 1555 1.33 LINK C MSE A 57 N AVAL A 58 1555 1555 1.33 LINK C MSE A 57 N BVAL A 58 1555 1555 1.33 LINK C GLY A 181 N MSE A 182 1555 1555 1.33 LINK C MSE A 182 N ILE A 183 1555 1555 1.33 LINK C LEU A 201 N AMSE A 202 1555 1555 1.33 LINK C LEU A 201 N BMSE A 202 1555 1555 1.34 LINK C AMSE A 202 N ALYS A 203 1555 1555 1.34 LINK C BMSE A 202 N BLYS A 203 1555 1555 1.34 LINK C CYS A 244 N MSE A 245 1555 1555 1.33 LINK C MSE A 245 N SER A 246 1555 1555 1.32 LINK C ASN A 272 N MSE A 273 1555 1555 1.33 LINK C MSE A 273 N ASN A 274 1555 1555 1.34 LINK C GLY A 283 N MSE A 284 1555 1555 1.32 LINK C MSE A 284 N GLY A 285 1555 1555 1.33 LINK C ALA A 287 N MSE A 288 1555 1555 1.33 LINK C MSE A 288 N AMSE A 289 1555 1555 1.33 LINK C MSE A 288 N BMSE A 289 1555 1555 1.33 LINK C AMSE A 289 N CYS A 290 1555 1555 1.33 LINK C BMSE A 289 N CYS A 290 1555 1555 1.33 LINK C GLU A 291 N AMSE A 292 1555 1555 1.34 LINK C GLU A 291 N BMSE A 292 1555 1555 1.33 LINK C AMSE A 292 N ILE A 293 1555 1555 1.33 LINK C BMSE A 292 N ILE A 293 1555 1555 1.33 LINK C LEU A 365 N MSE A 366 1555 1555 1.35 LINK C MSE A 366 N VAL A 367 1555 1555 1.33 LINK C CYS A 386 N MSE A 387 1555 1555 1.33 LINK C MSE A 387 N ARG A 388 1555 1555 1.33 LINK C ARG A 388 N MSE A 389 1555 1555 1.32 LINK C MSE A 389 N ASN A 390 1555 1555 1.33 CISPEP 1 ALA A 134 PRO A 135 0 2.55 CISPEP 2 ARG A 187 PRO A 188 0 -4.70 CISPEP 3 ASN A 190 PRO A 191 0 13.55 CISPEP 4 VAL A 223 PRO A 224 0 2.10 CISPEP 5 PHE A 225 PRO A 226 0 2.20 SITE 1 AC1 4 ASP A 56 SER A 60 LYS A 62 ARG A 295 SITE 1 AC2 1 HOH A 497 SITE 1 AC3 4 PHE A 309 GLN A 312 ARG A 313 HOH A 676 SITE 1 AC4 6 PHE A 230 LYS A 307 GLU A 415 HOH A 503 SITE 2 AC4 6 HOH A 536 HOH A 637 SITE 1 AC5 5 GLY A 15 ARG A 18 TYR A 356 TYR A 371 SITE 2 AC5 5 HOH A 480 SITE 1 AC6 4 ASN A 81 VAL A 85 ARG A 88 GLU A 96 CRYST1 92.280 92.280 227.330 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010837 0.006257 0.000000 0.00000 SCALE2 0.000000 0.012513 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004399 0.00000